Scott Sheftel, M.D, FAAD
NPI 1134128564 · Dermatology Physician · Tucson, AZ
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1134128564
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D, FAAD
- Sex
- Male
- Sole proprietor
- No
- License
- 18975 (AZ)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
4 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
14,681 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 4,475 | $6 |
| Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305 | 3,659 | $34 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 2,606 | $88 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 1,519 | $46 |
| Biopsy of Related Skin Growth, First Growth11102 | 479 | $83 |
| Destruction of Cancer Skin Growth of Trunk, Arms, Or Legs, 1.1-2.0 Cm17262 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 24 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 227 | 161 |
| Ketoconazole | 162 | 81 |
| Fluorouracil | 149 | 134 |
| Valacyclovir Hclbrand: Valacyclovir | 82 | 63 |
| Doxycycline Hyclate | 81 | 26 |
| Betamethasone Dipropionate | 79 | 39 |
| Hydrocortisone | 76 | 46 |
| Minoxidil | 64 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,559 across 86 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (3)
- 2295 E Vistoso Commerce LoopOro Valley, AZ 85755-9182Phone: (520) 293-5757Fax: (520) 293-7358
- 18855 S La Canada DrSahuarita, AZ 85629-8004Phone: (520) 293-5757Fax: (520) 293-7358
- 5190 E Farness Dr Ste 110Tucson, AZ 85712-2142Phone: (520) 293-5757Fax: (520) 293-7358
Registry dates
- Enumerated
- 2005-07-18
- Last updated
- 2021-11-11
- Certified
- 2021-11-11
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.